James Peyer, PhD, is the CEO & Founder of Cambrian Bio, a Distributed Drug Development Company focused on developing therapeutics targeting the biological drivers of ageing. Cambrian builds, directs, operates, and finances a pipeline of therapeutics. He founded the company to translate laboratory breakthroughs in the extension of healthy lifespan into the clinic with the mission of shifting the modern medicine approach from reactive to preventative.
 
Before Cambrian, Dr Peyer started Apollo Ventures, the first company builder in Longevity Therapeutics, where he was the founder, investor, and CEO of multiple companies. He did his PhD with a focus on blood stem cell biology as a National Science Foundation Fellow at UT Southwestern